MB11 (Proposed Nivolumab Biosimilar): clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

2

Countries

Phase breakdown

Phase 3 1

Conditions being studied

Condition	Trials
Advanced (Unresectable or Metastatic) Melanoma	1
Melanoma	1

Recruiting trials involving MB11 (Proposed Nivolumab Biosimilar)

Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma
NCT07221734 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 19 locations

Common questions

How many recruiting trials involve MB11 (Proposed Nivolumab Biosimilar)?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.